Correlative biomarkers in a phase II study of dasatinib (D) and weekly (w) paclitaxel (P) for patients (Pts) with metastatic breast carcinoma (MBC) Meeting Abstract


Authors: Morris, P. G.; Chang, J. C.; Abbruzzi, A.; Patil, S.; Modi, S.; Seidman, A. D.; Sklarin, N. T.; Norton, L.; Hudis, C.; Fornier, M. N.
Abstract Title: Correlative biomarkers in a phase II study of dasatinib (D) and weekly (w) paclitaxel (P) for patients (Pts) with metastatic breast carcinoma (MBC)
Meeting Title: 46th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 28
Issue: 15 Suppl.
Meeting Dates: 2010 Jun 4-8
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2010-05-20
Start Page: 13s
Language: English
ACCESSION: WOS:000208852002127
DOI: 10.1200/jco.2010.28.15_suppl.tps124
PROVIDER: wos
Notes: Meeting Abstract: TPS124 -- S -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Sujata Patil
    511 Patil
  2. Patrick Glyn Morris
    116 Morris
  3. Andrew D Seidman
    318 Seidman
  4. Clifford Hudis
    905 Hudis
  5. Larry Norton
    758 Norton
  6. Nancy T Sklarin
    54 Sklarin
  7. Monica Nancy Fornier
    158 Fornier
  8. Shanu Modi
    267 Modi
  9. Alyson Merced
    13 Merced